{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:26:38Z","timestamp":1781677598453,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.juro.2011.03.129","type":"journal-article","created":{"date-parts":[[2011,6,23]],"date-time":"2011-06-23T23:51:28Z","timestamp":1308873088000},"page":"448-451","source":"Crossref","is-referenced-by-count":66,"title":["A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Gu\u00e9rin Refractory Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"186","author":[{"given":"James M.","family":"McKiernan","sequence":"first","affiliation":[{"name":"Department of Urology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaMont J.","family":"Barlow","sequence":"additional","affiliation":[{"name":"Department of Urology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Laudano","sequence":"additional","affiliation":[{"name":"Department of Urology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Urology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Petrylak","sequence":"additional","affiliation":[{"name":"Department of Oncology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell C.","family":"Benson","sequence":"additional","affiliation":[{"name":"Department of Urology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2011.03.129_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2011.03.129_bib2","first-page":"2785","article-title":"Management of superficial bladder cancer","volume":"vol 4","author":"Malkowicz","year":"2002"},{"key":"10.1016\/j.juro.2011.03.129_bib3","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1200\/JCO.2002.20.15.3185","article-title":"Intravesical therapy for superficial cancer: need for more options","volume":"20","author":"Crawford","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.03.129_bib4","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0022-5347(17)49690-X","article-title":"Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer","volume":"132","author":"Morales","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib6","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-5347(17)37452-9","article-title":"Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup","volume":"147","author":"Herr","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib7","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/S0022-5347(01)66692-8","article-title":"Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results","volume":"154","author":"Pansadoro","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00002512-200118050-00004","article-title":"Medical management of patients with refractory carcinoma in situ of the bladder","volume":"18","author":"Kim","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.juro.2011.03.129_bib9","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/bjc.1998.681","article-title":"Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients","volume":"78","author":"de Wit","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2011.03.129_bib10","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.1999.17.8.2341","article-title":"Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer","volume":"17","author":"Chan","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.03.129_bib11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2011.03.129_bib12","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1200\/JCO.2005.03.1161","article-title":"Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy","volume":"24","author":"McKiernan","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.03.129_bib13","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","article-title":"Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol)","volume":"11","author":"Sparreboom","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2011.03.129_bib14","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2011.03.129_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5347(17)51695-X","article-title":"Superficial bladder cancer: progression and recurrence","volume":"130","author":"Heney","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-5347(17)56073-5","article-title":"Complications of radical cystectomy for carcinoma of the bladder","volume":"123","author":"Skinner","year":"1980","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2011.03.129_bib17","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1158\/1078-0432.CCR-07-4592","article-title":"Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel","volume":"14","author":"Gardner","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711035427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534711035427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2011.03.129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:16:06Z","timestamp":1651198566000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2011.03.129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.1016\/j.juro.2011.03.129"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2011.03.129","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}